| May. 08, 2008 | Print This | Email This |
| |
|
|
|
A live webcast of Dr. Hunter's remarks and the question and answer session will be available to all interested parties on the company's website, www.angiotech.com, under the Investors section.
About Angiotech
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech
CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com
Angiotech Pharmaceuticals, Inc.CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate
Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056,
dneary@angio.com

